UK's pharma regulator could issue a decision for Novo's Wegovy pill by year-end

Core Viewpoint - The UK's medicines regulator is reviewing Novo Nordisk's application for an oral 25 milligram version of the weight-loss drug Wegovy, with a decision expected by the end of the year [1] Group 1 - The application under review pertains to a new oral formulation of Wegovy, which is currently available in injectable form [1] - The anticipated decision timeline indicates a proactive approach by the regulator in evaluating new weight-loss treatment options [1]